Coston McIsaac & Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9
Closed -$2K 787
2025
Q1
$2K Hold
9
﹤0.01% 680
2024
Q4
$2K Hold
9
﹤0.01% 681
2024
Q3
$2K Hold
9
﹤0.01% 689
2024
Q2
$3K Hold
9
﹤0.01% 628
2024
Q1
$3K Hold
9
﹤0.01% 625
2023
Q4
$4K Hold
9
﹤0.01% 589
2023
Q3
$4K Hold
9
﹤0.01% 582
2023
Q2
$4K Hold
9
﹤0.01% 625
2023
Q1
$4K Hold
9
﹤0.01% 611
2022
Q4
$4K Hold
9
﹤0.01% 612
2022
Q3
$4K Hold
9
﹤0.01% 529
2022
Q2
$4K Buy
+9
New +$4K ﹤0.01% 367

Other funds holding HUM

Coston McIsaac & Partners's HUM Position: Q2 2025 in Review

Coston McIsaac & Partners sold out of Humana (HUM) in Q2 2025, closing a stake of 9 shares — an estimated $2K sold.

Coston McIsaac & Partners first reported a position in HUM in Q2 2022 and held it in 12 quarters. The position peaked at $4K in Q4 2023. 878 funds tracked by Wall St. Rank hold HUM as of Q2 2025.

  • Coston McIsaac & Partners reported no remaining Humana position as of Q2 2025 after selling out during the quarter.
  • Coston McIsaac & Partners sold 9 Humana shares in Q2 2025, an estimated $2K.
  • Coston McIsaac & Partners first reported a position in Humana in Q2 2022 and held it in 12 quarters.
  • Coston McIsaac & Partners's Humana position peaked at $4K in Q4 2023.
  • 878 funds tracked by Wall St. Rank held Humana as of Q2 2025.

Based on Coston McIsaac & Partners's 13F filing for Q2 2025, filed 12 Aug 2025.